Business Context and Reporting Period
Company: Accendra Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 9, 2026 (Event Date)
Reporting Period: The filing details the early settlement of exchange offers and consent solicitations for outstanding senior notes, with key transactions occurring between June 9, 2026, and June 15, 2026.
Key Financial Metrics and Capital Structure Changes
This filing focuses on debt restructuring rather than operating performance. No revenue, profit, or cash flow metrics are provided in this document.
- Existing Notes Retired: Approximately $478.3 million of 4.500% Senior Notes due 2029 (99.9% of outstanding) and $547.9 million of 6.625% Senior Notes due 2030 (99.2% of outstanding) were tendered and cancelled.
- Remaining Existing Notes: $363,000 of 2029 Notes and $4,257,000 of 2030 Notes remain outstanding.
- New Debt Issued (Exchange): $213.0 million of 9.000% Senior Secured First Lien Notes due 2032 and $698.0 million of 9.750% Senior Secured Second Lien Notes due 2033.
- New Debt Issued (New Money): $326.25 million of 9.000% Senior Secured First Lien Notes due 2032.
- Total New First Lien Notes: $539.25 million aggregate principal amount.
- Credit Facility: Established a new $300.0 million revolving credit facility due 2030 (with $50 million available only for M&A).
Material Changes Versus Prior Period
The company executed a significant liability management transaction, fundamentally altering its capital structure:
- Interest Rate Increase: Replaced unsecured notes with interest rates of 4.500% and 6.625% with secured notes bearing interest rates of 9.000% and 9.750%.
- Covenant Relaxation: Adopted amendments to the indentures for the remaining existing notes to eliminate substantially all affirmative and negative covenants and modify events of default.
- Security Status: The new notes are secured by first-priority and second-priority liens on substantially all assets, whereas the existing notes were unsecured.
- Liquidity Facility: Replaced the existing revolving credit facility with a new $300 million facility subject to a Total Leverage Covenant Ratio of less than 5.50:1.00 (until Jan 1, 2028) and a consolidated interest coverage ratio of at least 2.00:1.00.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Management Commentary: The company successfully secured sufficient consents to amend existing note indentures and issued new secured debt. The exchange offers for remaining holders expire on June 23, 2026, with a final settlement expected on June 25, 2026.
Risks and Contingencies:
- Transaction Completion: The exchange offers are subject to conditions; failure to complete them could materially adversely affect the company's financial condition.
- Increased Interest Burden: The restructuring significantly increases the cost of debt (from ~4.5-6.6% to 9.0-9.75%).
- Covenant Compliance: The new credit facility imposes strict leverage and interest coverage ratios. Non-compliance could trigger events of default.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks that could cause actual results to differ from expectations, including disruption of management attention and market conditions.
Important Facts for Investor Verification
- Verify the exact amount of cash interest expense increase resulting from the swap of ~$1.026 billion in old debt for ~$1.237 billion in new debt at higher rates.
- Confirm the company's current Total Leverage Ratio and Interest Coverage Ratio to ensure compliance with the new credit facility covenants (5.50:1.00 and 2.00:1.00, respectively).
- Review the "Risk Factors" in the most recent Form 10-K (period ended Dec 31, 2025) for updated risks related to the new secured debt structure.
- Monitor the final settlement of the exchange offers on June 25, 2026, to determine if any remaining existing notes are exchanged or if the company must manage a small residual unsecured debt position.
- Assess the impact of the new "make-whole" redemption premiums and change of control provisions on future refinancing flexibility.